VX-765 is a dipeptide compound and the orally available prodrug of a potent and selective competitive inhibitor of ICE/caspase-1 (VRT-043198). It is being investigated as a pharmaceutical raw material for research in inflammatory and autoimmune conditions.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing VX-765?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Intedanib Piperazinyl-N4-oxide
pharmaceutical raw material
Neladalkib
pharmaceutical raw material
Ambroxol-d5 (hydrochloride)
pharmaceutical raw material
2-[[(3aS,4R,6S,6aR)-4-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]oxy]ethanol
pharmaceutical raw material
The international HS code for VX-765 (CAS 273404-37-8) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2S)-1-[(2S)-2-[(4-amino-3-chlorobenzoyl)amino]-3,3-dimethylbutanoyl]-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]pyrrolidine-2-carboxamide
SJDDOCKBXFJEJB-MOKWFATOSA-N
CCO[C@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)(C)C)NC(=O)C3=CC(=C(C=C3)N)Cl
Sourcing VX-765?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.